3.05

1.61% -0.05

Heron Therapeutics Inc (HRTX)

Overview News Price History Option Chain Financials Why HRTX Down? Discussions Forecast Stock Split

Heron Therapeutics Inc stock is traded at $3.05, with a volume of 1.69M. It is down -1.61% in the last 24 hours and down -8.41% over the past month. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Previous Close:

$3.10

Open:

$3.15

24h Volume:

1.69M

Market Cap:

$459.49M

Revenue:

$127.04M

Net Income/Loss:

$-110.56M

P/E Ratio:

-2.6068

EPS:

-1.17

Net Cash Flow:

$-60.33M

1W Performance:

-6.15%

1M Performance:

-8.41%

6M Performance:

+22.49%

1Y Performance:

+84.85%

1D Range:

$3.03

$3.16

52W Range:

$0.50

$3.93

Heron Therapeutics Inc Stock (HRTX) Company Profile

Name

Heron Therapeutics Inc

Sector

Healthcare (1186)

Industry

Biotechnology (681)

Phone

(858) 251-4400

Address

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Employee

126

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

HRTX's Discussions on Twitter

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-27-20	Initiated	Guggenheim	Buy
Feb-20-20	Reiterated	Needham	Buy
Jan-16-19	Reiterated	Needham	Buy
Apr-05-18	Initiated	Evercore ISI	Outperform
Mar-19-18	Reiterated	Mizuho	Buy
Mar-01-18	Reiterated	Needham	Buy
Jan-03-18	Initiated	Leerink Partners	Outperform
Sep-27-17	Initiated	Northland Capital	Outperform
Feb-27-17	Initiated	Needham	Buy
Oct-26-16	Initiated	Aegis Capital	Buy
Sep-06-16	Resumed	Lake Street	Buy
May-03-16	Initiated	Cantor Fitzgerald	Buy
Dec-10-15	Initiated	Lake Street	Buy
Sep-23-15	Reiterated	Leerink Partners	Outperform
Sep-02-15	Initiated	BofA/Merrill	Buy
Aug-03-15	Reiterated	Brean Capital	Buy
Jun-30-15	Reiterated	JMP Securities	Mkt Outperform
Jun-19-15	Reiterated	Leerink Partners	Outperform
Aug-07-14	Initiated	Noble Financial	Buy

View All

Heron Therapeutics Inc Stock (HRTX) Latest News

While shareholders of Heron Therapeutics (NASDAQ:HRTX) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance

Yahoo Finance

There is no way Heron Therapeutics Inc (HRTX) can keep these numbers up - SETE News

SETE News

Daily Progress: Heron Therapeutics Inc (HRTX) Drop -1.54, Closing at 3.20 - The Dwinnex

The Dwinnex